These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 21757624

  • 1. Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease.
    Turino GM, Ma S, Lin YY, Cantor JO, Luisetti M.
    Am J Respir Crit Care Med; 2011 Sep 15; 184(6):637-41. PubMed ID: 21757624
    [Abstract] [Full Text] [Related]

  • 2. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation.
    Ma S, Turino GM, Lin YY.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul 01; 879(21):1893-8. PubMed ID: 21621489
    [Abstract] [Full Text] [Related]

  • 3. Elastin degradation: an effective biomarker in COPD.
    Turino GM, Lin YY, He J, Cantor JO, Ma S.
    COPD; 2012 Aug 01; 9(4):435-8. PubMed ID: 22734624
    [No Abstract] [Full Text] [Related]

  • 4. The role of desmosines as biomarkers for chronic obstructive pulmonary disease.
    Iadarola P, Luisetti M.
    Expert Rev Respir Med; 2013 Apr 01; 7(2):137-44. PubMed ID: 23547990
    [Abstract] [Full Text] [Related]

  • 5. Stable deuterium internal standard for the isotope-dilution LC-MS/MS analysis of elastin degradation.
    Ma S, Turino GM, Hayashi T, Yanuma H, Usuki T, Lin YY.
    Anal Biochem; 2013 Sep 15; 440(2):158-65. PubMed ID: 23727558
    [Abstract] [Full Text] [Related]

  • 6. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.
    Luisetti M, Ma S, Iadarola P, Stone PJ, Viglio S, Casado B, Lin YY, Snider GL, Turino GM.
    Eur Respir J; 2008 Nov 15; 32(5):1146-57. PubMed ID: 18978133
    [Abstract] [Full Text] [Related]

  • 7. Biomimetic Chichibabin pyridine synthesis of the COPD biomarkers and elastin cross-linkers isodesmosine and desmosine.
    Usuki T, Sugimura T, Komatsu A, Koseki Y.
    Org Lett; 2014 Mar 21; 16(6):1672-5. PubMed ID: 24597689
    [Abstract] [Full Text] [Related]

  • 8. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease.
    He J, Turino GM, Lin YY.
    Exp Lung Res; 2010 Nov 21; 36(9):548-57. PubMed ID: 20815658
    [Abstract] [Full Text] [Related]

  • 9. Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
    Turino GM, Ma S, Cantor JO, Lin YY.
    Ann Am Thorac Soc; 2016 Aug 21; 13 Suppl 4():S336-40. PubMed ID: 27564670
    [Abstract] [Full Text] [Related]

  • 10. Determination of free desmosine and isodesmosine as urinary biomarkers of lung disorder using ultra performance liquid chromatography-ion mobility-mass spectrometry.
    Devenport NA, Reynolds JC, Parkash V, Cook J, Weston DJ, Creaser CS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec 15; 879(32):3797-801. PubMed ID: 22088351
    [Abstract] [Full Text] [Related]

  • 11. Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.
    Fregonese L, Ferrari F, Fumagalli M, Luisetti M, Stolk J, Iadarola P.
    COPD; 2011 Oct 15; 8(5):329-33. PubMed ID: 21793711
    [Abstract] [Full Text] [Related]

  • 12. The effect of tiotropium therapy on markers of elastin degradation in COPD.
    Ma S, Lin YY, Tartell L, Turino GM.
    Respir Res; 2009 Feb 25; 10(1):12. PubMed ID: 19243601
    [Abstract] [Full Text] [Related]

  • 13. The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD.
    Liu X, Ma S, Liu S, Liu M, Turino G, Cantor J.
    Lung; 2015 Jun 25; 193(3):329-34. PubMed ID: 25762453
    [Abstract] [Full Text] [Related]

  • 14. Total desmosines in plasma and urine correlate with lung function.
    Lindberg CA, Engström G, de Verdier MG, Nihlén U, Anderson M, Forsman-Semb K, Svartengren M.
    Eur Respir J; 2012 Apr 25; 39(4):839-45. PubMed ID: 21965222
    [Abstract] [Full Text] [Related]

  • 15. The Therapeutic Potential of Hyaluronan in COPD.
    Turino GM, Ma S, Lin YY, Cantor JO.
    Chest; 2018 Apr 25; 153(4):792-798. PubMed ID: 29289686
    [Abstract] [Full Text] [Related]

  • 16. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S, Lin YY, He J, Rouhani FN, Brantly M, Turino GM.
    COPD; 2013 Aug 25; 10(4):473-81. PubMed ID: 23560990
    [Abstract] [Full Text] [Related]

  • 17. Measurements of desmosine and isodesmosine by mass spectrometry in COPD.
    Ma S, Lin YY, Turino GM.
    Chest; 2007 May 25; 131(5):1363-71. PubMed ID: 17494786
    [Abstract] [Full Text] [Related]

  • 18. Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy.
    Turino GM.
    Ann Am Thorac Soc; 2018 Feb 25; 15(Suppl 1):S15-S17. PubMed ID: 29461896
    [Abstract] [Full Text] [Related]

  • 19. [(13)C3,(15)N1]-labeled isodesmosine: A potential internal standard for LC-MS/MS analysis of desmosines in elastin degradation.
    Tanigawa T, Komatsu A, Usuki T.
    Bioorg Med Chem Lett; 2015 Feb 25; 25(10):2046-9. PubMed ID: 25890800
    [Abstract] [Full Text] [Related]

  • 20. Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease.
    Huang JT, Bolton CE, Miller BE, Tal-Singer R, Rabinovich RA, Palmer CN, Thomson NC, MacNee W, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
    Eur Respir J; 2016 Oct 25; 48(4):1215-1218. PubMed ID: 27587547
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.